Dr. Souheil Younes's research lab at Emory University focuses on understanding how the gut microbiome affects CD4 T cells in HIV-1 infected individuals who do not respond to treatment. The lab investigates the role of specific bacterial toxins produced in the gut that may hinder the recovery of CD4 T cells and contribute to health complications in these patients. By exploring the connections between bacteria, toxins, and immune response, the lab aims to identify new therapeutic targets to improve health outcomes for these individuals.

Dr. Steven S Welc's lab focuses on understanding the mechanisms behind cardiac disease in patients with Duchenne muscular dystrophy (DMD). They investigate how fibroblasts, which are cells that help maintain the structure of heart tissue, produce specific signals that can worsen heart problems associated with DMD. The goal is to find new ways to target these signals for potential therapies to improve heart function and overall health for affected individuals.

Dr. Emery H. Bresnick's lab at the University of Wisconsin-Madison focuses on understanding how specific genetic factors (GATA factors) regulate blood cell development. The research aims to uncover the mechanisms that control the behavior of blood stem cells and how genetic variations can lead to diseases like acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Through innovative models and genetic assessments, the lab seeks to improve strategies for diagnosing and treating blood-related disorders.

Dr. Margaret A. Goodell's lab focuses on understanding clonal hematopoiesis (CH), a pre-cancerous condition where certain blood cells expand due to genetic mutations. The lab investigates how different stressors, like inflammation and environmental factors, interact with these mutations to influence the risk of developing blood cancers. By using innovative mouse models and analyzing data from large human studies, their aim is to identify modifiable factors that could prevent the progression of CH into malignancies.

Dr. Christopher Sturgeon's lab focuses on understanding how blood cells develop in embryos, particularly how different early cell types contribute to the formation of blood and immune cells. By studying these early developmental processes, the lab aims to improve techniques for generating various blood cell types from stem cells, which could have significant applications in regenerative medicine and treatments for blood disorders. Their work investigates the roles of different cellular programs and signaling mechanisms in hematopoietic development.

Dr. Sichen Shao's lab at Harvard Medical School focuses on understanding how red blood cells develop and function by studying a special enzyme called UBE2O. This enzyme helps to manage the proteins needed to form healthy red blood cells, which are essential for carrying oxygen throughout the body. By exploring the mechanisms behind protein quality control and degradation, the lab aims to uncover important factors related to blood disorders and potential new therapies.

Dr. Jiandie D Lin's lab at the University of Michigan focuses on understanding metabolic liver diseases, especially nonalcoholic steatohepatitis (NASH), which is a serious condition that can lead to liver damage and other health issues. The lab investigates the cellular and molecular mechanisms that contribute to liver disease, how certain cell types like macrophages are involved, and explores innovative pathways that could lead to new treatments. Their research aims to uncover insights that could help in developing effective therapies for liver diseases related to obesity.

Dr. Qitao Ran's research lab at the University of Texas Health Science Center focuses on Alzheimer's disease, exploring innovative ways to target the Hippo signaling pathway to develop new treatments. This pathway is crucial for regulating cell growth and survival, and its abnormal activation has been linked to neurodegeneration. The lab conducts studies using mouse models to better understand how inhibiting this pathway can improve cognitive function and protect neurons from damage in Alzheimer's disease.

Dr. Malek Kamoun's lab at the University of Pennsylvania focuses on improving kidney transplant outcomes by studying HLA immunogenetics. They investigate how variations in HLA proteins affect the body’s immune response to transplanted kidneys. By utilizing advanced machine learning techniques and extensive genetic data, the lab aims to refine donor-recipient matching and optimize immunosuppressive therapies, ultimately enhancing the success rates of kidney transplants.

Esteban Mazzoni's lab at NYU School of Medicine focuses on understanding how Hox genes, which are essential for the body's development, maintain their positional identity through epigenetic memory. The lab investigates how different signaling factors interact with chromatin to properly activate or repress these genes during cell differentiation. This research has implications for understanding developmental processes and diseases such as cancer.

Dr. Thomas C. Resta's lab focuses on understanding how chronic hypoxia affects vascular health, specifically in the context of pulmonary hypertension. The research examines the role of oxidative signaling mechanisms that change how cells in the lungs respond to various stimuli. By investigating how changes in cholesterol and reactive oxygen species contribute to vascular dysfunction, the lab aims to uncover new treatment strategies for chronic lung diseases.

Dr. Kiera L. Clayton's lab at the University of Massachusetts Medical School focuses on understanding how the HIV virus and Mycobacterium tuberculosis (Mtb) evade the immune system, particularly by manipulating natural killer (NK) cells and macrophages. The lab investigates the interactions between these pathogens and immune cells to uncover new mechanisms of immune evasion, aiming to enhance the effectiveness of immune responses and develop new therapeutic strategies.

Dr. Daniel Kalman’s lab at Emory University studies how natural compounds produced by gut bacteria, called indoles, can help maintain muscle function and mobility as animals age. The lab investigates how indoles can protect muscle proteins and mitochondrial function, helping to combat age-related decline in mobility and associated health issues in elderly populations. Their research may lead to new therapies to support healthy aging.

Dr. Paul Garrity's lab at Brandeis University studies how insects detect sugars and regulate their behaviors through internal clocks. They explore molecular mechanisms in fruit flies and mosquitoes, focusing on how sensory receptors work and how circadian rhythms affect feeding patterns. This research is important not just for understanding insect biology, but also for finding ways to control disease transmission by mosquitoes.

Dr. Amy E. Keating's lab at MIT focuses on understanding protein-protein interactions, which are critical for cellular functions and can play a role in diseases. The lab combines computational techniques with experimental methods to map these interactions, especially targeting short linear motifs that can bind to various proteins. By studying these interactions, the lab aims to uncover how specific proteins interact in healthy and disease states, which could lead to innovative therapies.

Dr. David Sherwood's lab at Duke University focuses on understanding how cells invade through the basement membrane, a crucial structure surrounding tissues. This research is significant because cell invasion plays a role in both healthy processes like tissue development and in diseases such as cancer and multiple sclerosis. By using the model organism C. elegans, the lab explores how cells manage energy and create structures necessary for breaching these membranes, which could lead to better treatments for diseases involving abnormal cell invasion.

Thales Papagiannakopoulos's lab focuses on understanding and treating aggressive forms of lung cancer driven by KRAS mutations, particularly those with mutations in the KEAP1 gene. They explore novel therapeutic strategies that target specific metabolic vulnerabilities and immune evasion mechanisms in these tumors, aiming to improve treatment options for patients with KRAS mutant lung cancer.

Dr. Christine A Petersen's research lab at Ohio State University focuses on understanding how skin immune responses influence the transmission of Leishmania, a parasite that causes serious illness in both dogs and humans. By studying the interactions between the parasite, sand flies that spread the infection, and the immune system in the skin, her work aims to develop better strategies for controlling Visceral Leishmaniasis, a disease that poses significant health risks. The lab explores innovative therapeutic approaches to modify immune responses and curb the disease's spread.

Dr. Elsio Augusto Wunder's lab at the University of Connecticut focuses on developing a universal vaccine for leptospirosis, an infectious disease that affects both humans and animals. The lab is particularly interested in identifying protective immune responses against various strains of the disease-causing bacteria, Leptospira spp. They aim to create a vaccine that can effectively prevent this neglected tropical disease, which poses significant health risks in both developing and urban populations.

Iannis Aifantis' lab at NYU focuses on understanding the mechanisms of acute myeloid leukemia (AML) and other blood cancers. The research explores how RNA-binding proteins affect cell differentiation and how inflammation impacts the immune response in leukemia. By using advanced techniques like CRISPR, the lab aims to identify new therapeutic targets and improve treatment outcomes for leukemia patients.